Indolizine: A biologically active moiety

Medicinal Chemistry Research

Volumn 23, Issue 8, 2014, Pages 3593-3606

  Sharma, Vikas ^a   Kumar, Vipin ^a,b  

^a KURUKSHETRA UNIVERSITY   (India)

^b CENTRAL UNIVERSITY OF RAJASTHAN   (India)

Author keywords

Biologically active; Camptothecin; Derivative; Heterocyclic; Indolizine; Moiety; Review

Indexed keywords

ANTIHISTAMINIC AGENT; ANTIMUTAGENIC AGENT; AROMATASE INHIBITOR; INDOLIZINE DERIVATIVE; LIPOXYGENASE INHIBITOR; NEUROKININ 2 RECEPTOR ANTAGONIST; PHOSPHODIESTERASE INHIBITOR; PROTEIN TYROSINE PHOSPHATASE INHIBITOR;

ANALGESIC ACTIVITY; ANTIBACTERIAL ACTIVITY; ANTIDIABETIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIPROTOZOAL ACTIVITY; BINDING AFFINITY; DRUG MECHANISM; DRUG SCREENING; DRUG SYNTHESIS; HERBICIDAL ACTIVITY; HUMAN; NONHUMAN; REVIEW; STRUCTURE ACTIVITY RELATION;

EID: 84904440217     PISSN: 10542523     EISSN: 15548120     Source Type: Journal    
DOI: 10.1007/s00044-014-0940-1     Document Type: Review

References (100)

1. Abele E, Abele R, Lukevics E (2003) Pyridine oximes: synthesis, reactions, and biological activity (Review). Chem Heterocycl Compd 39(7):825-865
2. Abele E, Abele R, Lukevics E (2004) Pyrrole oximes: synthesis, reactions, and biological activity (Review). Chem Heterocycl Compd 40(1):1-15
3. Baumer W, Hoppmann J, Rundfeldt C, Kietzmann M (2007) Highly selective phosphodiesterase 4 inhibitors for the treatment of allergic skin diseases and psoriasis. Inflamm Allergy Drug Targets 6(1):17-26 (Pubitemid 46488295)
4. Bloch WM, Derwent-Smith SM, Issa F, Morris JC, Rendina LM, Sumby CJ (2011) Fused pyrazino [2, 3-b] indolizine and indolizino [2, 3-b] quinoxaline derivatives; synthesis, structures, and properties. Tetrahedron 67(48):9368-9375
5. Burris HA, Rivkin S, Reynolds R, Harris J, Wax A, Gerstein H, Mettinger KL, Staddon A (2005) Phase II trial of oral rubitecan in previously treated pancreatic cancer patients. Oncologist 10(3):183-190 (Pubitemid 40463155)
6. Butler MS (2004) The role of natural product chemistry in drug discovery. J Nat Prod 67(12):2141-2153 2004
7. Butler MS (2005) Natural products to drugs: natural product derived compounds in clinical trials. Nat Prod Rep 22(2):162-195
8. Butler MS (2008) Natural products to drugs: natural product-derived compounds in clinical trials. Nat Prod Rep 25(3):475-516
9. Chai W, Breitenbucher JG, Kwok A, Li X, Wong V, Carruthers NI, Lovenberg TW, Mazur C, Wilson SJ, Axe FU, Jones TK (2003) Non-imidazole heterocyclic histamine H3 receptor antagonists. Bioorg Med Chem Lett 13(10):1767-1770 (Pubitemid 36561161)
10. Chandrashekhar N, Karvekar MD, Das AK (2008) Synthesis and antioxidant activity of 3, 3′-diselanediylbis(N, N-disubstituted indolizine-1- carboxamide):and derivatives. S Afr J Chem 61:53-55
11. Chen S, Xia Z, Nagai M, Lu R, Kostik E, Przewloka T, Song M, Chimmanamada D, James D, Zhang S, Jiang J, Ono M, Koya K, Sun L (2011) Novel indolizine compounds as potent inhibitors of phosphodiesterase IV(PDE4): structure-activity relationship. MedChemComm 2(3):176-180
12. Cheng Y, An LK, Wu N, Wang XD, Bu XZ, Huang ZS, Gu LQ (2008) Synthesis, cytotoxic activities and structure-activity relationships of topoisomerase I inhibitors: indolizinoquinoline-5,12-dione derivatives. Bioorg Med Chem 16(8):4617-4625 (Pubitemid 351539023)
13. Cingolani GM, Claudi F, Venturi F (1988) Indolizine derivatives with biological activity V 1-(2-Aminoethyl)-2-methylindolizine and its N-alkyl derivatives. Eur J Med Chem 23(3):291-294
14. Cingolani GM, Claudi F, Massi M, Venturi F (1990) Indolizine derivatives with biological activity VI 1-(2-aminoethyl)-3-benzyl-7-methoxy-2- methylindolizine, benanserin structural analogue. Eur J Med Chem 25(8):709-712
15. Clive DLJ, Yang H, Lewanczuk RZ (2001) Synthesis and in vitro activity of a non-epimerizable analog of the angiotensin-converting enzyme inhibitor A58365A. CR Acad Sci Ser IIc: Chim 4(6):505-512 (Pubitemid 33376684)
16. Colditz GA, Hankinson SE, Hunter DJ, Willett WC, Manson JE, Stampfer MJ, Hennekens C, Rosner B, Speizer FE (1995) The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 332(24):1589-1593
17. Dallavalle S, Ferrari A, Biasotti B, Merlini L, Penco S, Gallo G, Marzi M, Tinti MO, Martinelli R, Pisano C, Carminati P, Carenini N, Beretta G, Perego P, De Cesare M, Pratesi G, Zunino F (2001) Novel 7-oxyiminomethyl derivatives of camptothecin with potent in vitro and in vivo antitumor activity. J Med Chem 44(20):3264-3274 (Pubitemid 32917106)
18. Dannhardt G, Meindl W, Gussmann S, Ajili S, Kappe T (1987) Antimycobacterial 7-hydroxy-2, 3-dihydro-1H-indolizin-5-ones. Eur J Med Chem 22(6):505-510
19. Darwish ES (2008) Facile synthesis of heterocycles via 2-picolinium bromide and antimicrobial activities of the products. Molecules 13(5):1066-1078
20. De Cesare M, Pratesi G, Perego P, Carenini N, Tinelli S, Merlini L, Penco S, Pisano C, Bucci F, Vesci L, Pace S, Capocasa F, Carminati P, Zunino F (2001) Potent antitumor activity and improved pharmacological profile of ST1481, a novel 7-substituted camptothecin. Cancer Res 61(19):7189-7195 (Pubitemid 32946514)
21. Demarquay D, Huchet M, Coulomb H, Lesueur-Ginot L, Lavergne O, Camara J, Kasprzyk PG, Prevost G, Bigg DC (2004) BN80927: a novel homocamptothecin that inhibits proliferation of human tumor cells in vitro and in vivo. Cancer Res 64(14):4942-4949 (Pubitemid 38924541)
22. Devine MD, Duke SO, Fedtke C (1993) Physiology of herbicide action. Prentice Hall, New Jersey
23. DeVinney R, Steele-Mortimer O, Finlay BB (2000) Phosphatases and kinases delivered to the host cell by bacterial pathogens. Trends Microbiol 8(1):29-33 (Pubitemid 30066381)
24. Gundersen LL, Negussie AH, Rise F, Ostby OB (2003) Antimycobacterial activity of 1-substituted indolizines. Arch Pharm Pharm Med Chem 336(3):191-195 (Pubitemid 36790988)
25. Guo W, Miao Z, Sheng C, Yao J, Liu W, Zhu L, Zhang Y, Cheng P, Dong G, Zhuang C, Zhang W (2011) Synthesis of 9-(heteroarylmethylidene) amino derivatives of homocamptothecin with biological activities. Chem Biodivers 8(7):1266-1273
26. Hagishita S, Yamada M, Shirahase K, Okada T, Murakami Y, Ito Y, Matsuura T, Wada M, Kato T, Ueno M, Chikazawa Y, Yamada K, Ono T, Teshirogi I, Ohtani M (1996) Potent inhibitors of secretory phospholipase A2: synthesis and inhibitory activities of indolizine and indene derivatives. J Med Chem 39(19):3636-3658 (Pubitemid 26307871)
27. Harrell WB, Doerge RF (1967) Mannich bases from 2-phenylindolizines I 3-Alkyl-1-dialkylaminomethyl derivatives. J Pharm Sci 56(2):225-228
28. Hazra A, Mondal S, Maity A, Naskar S, Saha P, Paira R, Sahu KB, Paira P, Ghosh S, Sinha C, Samanta A, Banerjee S, Mondal NB (2011) Amberlite-IRA-402(OH): ion exchange resin mediated synthesis of indolizines, pyrrolo [1,2-a] quinolines and isoquinolines: antibacterial and antifungal evaluation of the products. Eur J Med Chem 46(6):2132-2140
29. Hohenschutz LD, Bell EA, Jewess PJ, Leworthy DP, Pryce RJ, Arnold E, Clardy J (1981) Castanospermine, A 1,6,7,8-tetrahydroxyoctahydroindolizine alkaloid, from seeds of Castanospermum australe. Phytochemistry 20(4):811-814
30. Hori K, Saito S (2003) Microvascular mechanisms by which the combretastatin A-4 derivative AC7700(AVE8062):induces tumour blood flow stasis. Br J Cancer 89(7):1334-1344 (Pubitemid 37363426)
31. Houslay MD, Schafer P, Zhang KY (2005) Keynote review: phosphodiesterase-4 as a therapeutic target. Drug Discov Today 10(22):1503-1519 (Pubitemid 41527193)
32. Huang Z, Mancini JA (2006) Phosphodiesterase 4 inhibitors for the treatment of asthma and COPD. Curr Med Chem 13(27):3253-3562 (Pubitemid 44669773)
33. Hunt AH, Mynderse JS, Samlaska SK, Fukuda DS, Maciak GM, Kirst HA, Occolowitz JL, Swartzendruber JK, Jones ND (1988) Structure elucidation of A58365A and A58365B, angiotensin converting enzyme inhibitors produced by Streptomyces chromofuscus. J Antibiot 41(6):771-779
34. Ipsen (2008) An innovation driven International Specialty Pharma http://www.ipsen.com/wpcontent/uploads/2013/02/20080318. Lehman brothers 10th annual global healthcare conference Miami 11.pdf. Accessed 23 Jan 2014
35. Ipsen (2012) Diflomotecan (BN80915) Administered Once Every 3 Weeks in Treating Patients With Sensitive Small Cell Lung Cancer (SCLC). http://apps.who.int/trialsearch/trial.aspx?trialid=NCT00080015. Accessed 23 Jan 2014
36. Jaisankar P, Pal B, Manna RK, Pradhan PK, Medda S, Basu MK, Giri VS (2003) Synthesis of antileishmanial(5R)-(-)-5-carbomethoxy-3-for-myl-5, 6-dihydroindolo-[2, 3-a]-indolizine. ARKIVOC ix:150-157
37. James DA, Koya K, Li H, Liang G, Xia Z, Ying W, Wu Y, Sun L (2008) Indole- and indolizine-glyoxylamides displaying cytotoxicity against multidrug resistant cancer cell lines. Bioorg Med Chem Lett 18(6):1784-1787 (Pubitemid 351380911)
38. Jean-Pierre J, Levade T, Thurneyssen O, Chiron M, Bordier C, Michel Attal, Pierre Chatelain, Laurent G (1992) In vitro and in vivo enhancement of ricin-A chain immunotoxin activity by novel indolizine calcium channel blockers: delayed intracellular degradation linked to lipidosis induction. Cancer Res 52(5):1352-1359
39. Jorgensen AS, Jacobsen P, Christiansen LB, Bury PS, Kanstrup A, Thorpe SM, Bain S, Naerum L, Wassermann K (2000a) Synthesis and pharmacology of a novel pyrrolo[2,1,5-cd] indolizine(NNC 45-0095), a high affinity non-steroidal agonist for the estrogen receptor. Bioorg Med Chem Lett 10(4):399-402 (Pubitemid 30127869)
40. Jorgensen AS, Jacobsen P, Christiansen LB, Bury PS, Kanstrup A, Thorpe SM, Naerum L, Wassermann K (2000b) Synthesis and estrogen receptor binding affinities of novel pyrrolo[2,1,5-cd]indolizine derivatives. Bioorg Med Chem Lett 10(20): 2383-2386
41. Kharb R, Bansal K, Sharma AK (2012) A valuable insight into recent advances on antimicrobial activity of piperazine derivatives. Der Pharma Chemica 4(6):2470-2488
42. Kim ND, Park ES, Kim YH, Moon SK, Lee SS, Ahn SK, Yu DY, No KT, Kim KH (2010) Structure-based virtual screening of novel tubulin inhibitors and their characterization as anti-mitotic agents. Bioorg Med Chem 18(19):7092-7100
43. Kim GM, Kim YS, Kang YA, Jeong J-H, Kim SM, Hong YK, Sung JH, Lim ST, Kim JH, Kim SK, Cho BC (2012) Efficacy and toxicity of Belotecan for relapsed or refractory small cell lung cancer patients. J Thorac Oncol 7(4):731-736
44. Koul A, Choidas A, Treder M, Tyagi AK, Drlica K, Singh Y, Ullrich A (2000) Cloning and characterization of secretory tyrosine phosphatases of Mycobacterium tuberculosis. J Bacteriol 182(19):5425-5432
45. Kumar S, Bawa S, Gupta H (2009) Biological activities of quinoline derivatives Mini-Rev. Med Chem 9(14):1648-1654
46. Kumari S, Sharma PK, Kumar N (2010) Imidazole and its biological activities: a review. Chem Sin 1:36-47
47. Lagoja IM (2005) Pyrimidine as constituent of natural biologically active compounds. Chem Biodivers 2(1):1-50
48. Lee WS, Kanai Y, Wells RG, Hediger MA (1994) The high affinity Na+/glucose cotransporter. Re-evaluation of function and distribution of expression. J Biol Chem 269(16):12032-12039
49. Leurs R, Blandina P, Tedford C, Timmerman H (1998) The histamine H3 receptor; a target for new drugs, 1st edn. Elsevier, Amsterdam, p 177
50. Li H, Xia Z, Chen S, Koya K, Ono M, Sun L (2007) Development of a practical synthesis of STA-5312, a novel indolizine oxalylamide microtubule inhibitor. Org Process Res Dev 11:246-250
51. Lobo RA (1997) The post menopausal state and estrogen deficiency. In: Lindsay R, Dempster DW Jordan VC Estrogens and Antiestrogen, Lippincott-Raven, Philadelphia, pp 63-72
52. Lv H, Ren J, Ma S, Xu S, Qu J, Liu Z, Zhou Q, Chen X, Yu S (2012) Synthesis, biological evaluation and mechanism studies of deoxytylophorinine and its derivatives as potential anticancer agents. PLoS ONE 7(1):e30342
53. Mackenzie B, Panayotova-Heiermann M, Loo DD, Lever JE, Wright EM (1994) SAAT1 is a low affinity Na+/glucose cotransporter and not an amino acid transporter. A reinterpretation. J Biol Chem 269(36):22488-22491
54. Mederski W, Beier N, Burgdorf LT, Gericke R, Klein M, Tsaklakidis C (2012) Indolizine derivatives and the use thereof as antidiabetics. US Patent 8,106,067 B2, Jan 31, 2012
55. Miller KJ, Newlin DD (1982) Interactions of molecules with nucleic acids VI Computer design of chromophoric intercalating agents. Biopolymers 21(3):633-652
56. Millet R, Domarkas J, Rigo B, Goossens L, Goossens JF, Houssin R, Henichart JP (2002) Novel potent substance P and neurokinin A receptor antagonists Conception, synthesis and biological evaluation of indolizine derivatives. Bioorg Med Chem 10(9):2905-2912 (Pubitemid 34763824)
57. Mishra BB, Tiwari VK (2011) Natural products in drug discovery: Clinical evaluations and investigations. Opportunity Challenge and Scope of Natural Products in Medicinal Chemistry p. 1-61
58. Moore MH, Hunter WN, d'Estaintot BL, Kennard O (1989) DNA-drug interactions The crystal structure of d(CGATCG):complexed with daunomycin. J Mol Biol 206(4):693-705 (Pubitemid 19137423)
59. Mynderse JS, Samlaska SK, Fukuda DS, Du Bus RH, Baker PJ (1985) Isolation of A58365A and A58365B, angiotensin converting enzyme inhibitors produced by Streptomyces chromofuscus. J Antibiot 38(8):1003-1007 (Pubitemid 15246221)
60. Nasir AI, Gundersen LL, Rise F, Antonsen O, Kristensen T, Langhelle B, Bast A, Custers I, Haenen GR, Wikstrom H (1998) Inhibition of lipid peroxidation mediated by indolizines. Bioorg Med Chem Lett 8(14):1829-1832 (Pubitemid 28338001)
61. Nihei Y, Suga Y, Morinaga Y, Ohishi K, Okano A, Ohsumi K, Hatanaka T, Nakagawa R, Tsuji T, Akiyama Y, Saito S, Hori K, Sato Y, Tsuruo T (1999) A novel combretastatin A-4 derivative, AC-7700, shows marked antitumor activity against advanced solid tumors and orthotopically transplanted tumors. Jpn J Cancer Res 90(9):1016-1025 (Pubitemid 29500443)
62. Olejnikova P, Birosova L, Svorc L (2009) Antimicrobial and antimutagenic properties of newly synthesized derivatives of indolizine. Sci Pharm 77:216
63. Pandey G, Dumbre SG, Pal S, Khan MI, Shabab M (2007) Synthesis and evaluation of 1-deoxy-8-epi-castanospermine, 1-deoxy-8-hydroxymethyl castanospermine, and(6S,7S,8R,8aR)-8-amino-octahydroindolizine-6,7-diol. Tetrahedron 63(22):4756-4761 (Pubitemid 46627800)
64. Patent Evaluation (1993) Indolizine 5α-reductase inhibitors. Expert Opin Ther Pat 3(5):597-599
65. Pathak D, Sharma G, Sharma V, Aggarwal S (2011) Synthesis and biological evaluation some novel indoles. Ind J Het Chem 20:401-402
66. Pratesi G, Beretta GL, Zunino F (2004) Gimatecan, a novel camptothecin with a promising preclinical profile. Anticancer Drugs 15(6):545-552 (Pubitemid 38932320)
67. Ranga R, Sharma V, Kumar V (2013) New thiazolidinyl analogs containing pyridine ring: synthesis, biological evaluation and QSAR studies. Med Chem Res 22(4):1538-1548
68. Sharma V, Kumar P, Pathak D (2010) Biological importance of the indole nucleus in recent years: a comprehensive review. J Het Chem 47:491-502
69. Sharma V, Kumar V, Kumar P (2013) Heterocyclic chalcone analogues as potential anticancer agents. Anticancer Agents Med Chem 13:422-432
70. Shen YM, Lv PC, Chen W, Liu PG, Zhang MZ, Zhu HL (2010) Synthesis and antiproliferative activity of indolizine derivatives incorporating a cyclopropylcarbonyl group against Hep-G2 cancer cell line. Eur J Med Chem 45(7):3184-3190
71. Shigemitsu Y, Komiya K, Mizuyama N, Tominaga Y (2008) TD-DFT investigation on the electronic spectra of novel N-methylmaleimides linked with indolizine ring system. THEOCHEM 855 (1-3):92-101
72. Shiose Y, Ochi Y, Kuga H, Yamashita F, Hashida M (2007) Relationship between drug release of DE-310, macromolecular prodrug of DX-8951f, and cathepsins activity in several tumors. Biol Pharm Bull 30(12):2365-2370 (Pubitemid 350223744)
73. Siegrist R, Zürcher M, Baumgartner C, Seiler P, Diederich F, Daum S, Fischer G, Klein C, Dangl M, Schwaiger MA (2007) Novel synthesis of highly substituted perhydropyrrolizines, perhydroindolizines, and pyrrolidines: inhibition of the peptidyl-prolyl cis/trans isomerase(PPIase):pin1. Helv Chim Acta 90(2):217-259 (Pubitemid 46931558)
74. Simpson ER, Mahendroo MS, Means GD, Kilgore MW, Jo Corbin C, Mendelson CR (1993) Tissue-specific promoters regulate aromatase cytochrome P450 expression. J Steroid Biochem Mol Biol 44(4):321-330 (Pubitemid 23126602)
75. Singh GS, Mmatli EE (2011) Recent progress in synthesis and bioactivity studies of indolizines. Eur J Med Chem 46(11):5237-5257
76. Sinha J, Raay B, Das N, Medda S, Garai S, Mahato SB, Basu MK (2002) Bacopasaponin C: critical evaluation of anti-leishmanial properties in various delivery modes. Drug Deliv 9(1):55-62 (Pubitemid 34171335)
77. Sisodiya PS (2013) Plant derived anticancer agents: a review. Int J Res Dev Pharm L Sci 2(2):293-308
78. Smith SC, Clarke ED, Ridley SM, Bartlett D, Greenhow DT, Glithro H, Klong AY, Mitchell G, Mullier GW (2005) Herbicidal indolizine-5,8-diones: photosystem I redox mediators. Pest Manag Sci 61(1):16-24 (Pubitemid 40065144)
79. Sonnet P, Dallemagne P, Guillon J, Enguehard C, Stiebing S, Tanguy J, Bureau R, Rault S, Auvray P, Moslemi S, Sourdaine P, Seralini GE (2000) New aromatase inhibitors synthesis and biological activity of aryl-substituted pyrrolizine and indolizine derivatives. Bioorg Med Chem 8(5):945-955 (Pubitemid 30336391)
80. Stanford JL, Weiss NS, Voigt LF, Daling JR, Habel LA, Rossing MA (1995) Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women. JAMA 274(2):137-142
81. Teklu S, Gundersen LL, Larsen T, Malterud KE, Rise F (2005) Indolizine 1-sulfonates as potent inhibitors of 15-lipoxygenase from soybeans. Bioorg Med Chem 13(9):3127-3139 (Pubitemid 40467563)
82. Tomlin CDS (2000) The pesticide manual, 12th edn. British Crop Protection Council, Farnham
83. Tomlin, CDS (2002-2003) The e-pesticide manual. Version 22; British Crop Protection Council, Farnham, Surrey
84. Tukulula M, Klein R, Kaye PT (2010) Indolizine studies, part 5: indolizine-2-carboxamides as potential hiv-1 protease inhibitors. Synth Commun 40(13):2018-2028
85. Unknown (2013) Drugs in clinical development for lung cancer: summary and table. Pharm Med 27(2):95-127
86. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J (2007) Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem 39(1):44-84 (Pubitemid 44566469)
87. Vaught JL, Raffa RB (1991) Centrally-mediated antinociceptive action of RWJ-22757 (formerly McN-5195): involvement of spinal descending inhibitory pathways (a hypothesis). Life Sci 48(23):2233-2241
88. Vaught JL, Carson JR, Carmosin RJ, Blum PS, Persico FJ, Hageman WE, Shank RP, Raffa RB (1990) Antinociceptive action of McN-5195 in rodents: a structurally novel (indolizine) analgesic with a nonopioid mechanism of action. J Pharmacol Exp Ther 255(1):1-10 (Pubitemid 20361474)
89. Vemula V, Vurukonda S, Bairi C (2011) Indolizine derivatives: recent advances and potential pharmacological activities Int J Pharm Sci Rev Res 11:159-163
90. Wadsworth DH, Bender SL, Smith DL, Luss HR, Weidner CH (1986) Indolizines 2 Preparation of 1- and 3-indolizinols and their esters. J Org Chem 51(24):4639-4644
91. Wadsworth DH, Weidner CH, Bender SL, Nuttall RH, Luss HR (1989) Indolizines 3 Oxidation products of indolizinols: radicals, ions, and oxidized dimers. J Org Chem 54(15):3652-3660
92. Wall ME, Wani MC, Cook CE, Palmer KH, McPhail HT, Sim GA (1966) Plant antitumor agents 1 The isolation and structure of camptothecin, a novel alkaloidal leukemia and tumor inhibitor from Camptotheca acuminate. J Am Chem Soc 88:3888-3890
93. Weide T, Arve L, Prinz H, Waldmann H, Kessler H (2006) 3-Substituted indolizine-1-carbonitrile derivatives as phosphatase inhibitors. Bioorg Med Chem Lett 16(1):59-63 (Pubitemid 41625641)
94. Weidner CH, Wadsworth DH, Bender SL, Beltman DJ (1989) Indolizines 4 dyes derived from oxoindolizinium ions and active methylene compounds. J Org Chem 54(15):3660-3664
95. Weidner CH, Michaels FM, Beltman DJ, Montgomery CJ, Wadsworth DH, Briggs BT, Picone ML (1991) Indolizines 5 preparation and structural assignments of azaindolizinols. J Org Chem 56(19):5594-5598
96. Wu N, Wu XW, Agama K, Pommier Y, Du J, Li D, Gu LQ, Huang ZS, An LK (2010) A novel DNA topoisomerase I inhibitor with different mechanism from camptothecin induces G2/M phase cell cycle arrest to K562 cells. Biochemistry 49(47):10131-10136
97. Yokota Y, Hanasaki K, Ono T, Nakazato H, Kobayashi T, Arita H (1999) Suppression of murine endotoxic shock by sPLA2 inhibitor, indoxam, through group IIA sPLA2-independent mechanisms. Biochim Biophys Acta 1438(2):213-222 (Pubitemid 29236127)
98. Zhang Y (2005) Magic bullets and tuberculosis drug targets. Annu Rev Pharmacool Toxicol 45:529-564
99. Zhang KY, Ibrahim PN, Gillette S, Bollag G (2005) Phosphodiesterase-4 as a potential drug target. Expert Opin Ther Targets 9(6):1283-1305 (Pubitemid 41762878)
100. Zhu L, Zhang X, Lei N, Liu W, Miao Z, Zhuang C, Sheng C, Guo W, Dong G, Yao J, Cheng P, Zhang W (2012) Synthesis and biological evaluation of 7-alkenyl homocamptothecins as potent topoisomerase I inhibitors. Chem Biodivers 9(6):1084-1094